Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04642729 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fresh Corneal Lenticule Implantation in Macular Corneal Distrophy With Relex Smile Surgery

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Jun 1, 2025 to Jun 1, 2027v6
  2. Study completion date: Jun 1, 2024 to Jun 1, 2025v5
  3. 2 versions Re-verified since Aug 18, 2021, no change to tracked fieldsv3-v4
  4. Enrollment target: 10 to 15
    • Study completion date: Jun 1, 2022 to Jun 1, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study is to examine the effect of fresh corneal lenticule implantation as allogenic graft taken from myopic patients to implanted in patients with macular corneal dystrophy using Visumax Femtosecond Laser Smile module surgery.
Trial Details
NCT Number NCT04642729
Lead Sponsor Eye Hospital Pristina Kosovo
Conditions
(from sponsor)		 Macular Corneal Dystrophy
Related terms Corneal Dystrophies, Hereditary
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov